Bile acids in the colon, from healthy to cytotoxic molecules

Toxicology in Vitro

Volumn 27, Issue 2, 2013, Pages 964-977

  Barrasa, Juan I ^a   Olmo, Nieves ^a   Lizarbe, Ma Antonia ^a   Turnay, Javier ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Apoptosis; Bile acids; Colon; Colorectal cancer; Oxidative stress

Indexed keywords

BILE ACID; DEATH RECEPTOR; URSODEOXYCHOLIC ACID;

APOPTOSIS; CELL POPULATION; CELL PROTECTION; COLON; COLON CELL; COLON MUCOSA; COLORECTAL CANCER; CYTOTOXICITY; DNA DAMAGE; DRUG MECHANISM; ENDOPLASMIC RETICULUM; EPITHELIUM CELL; HUMAN; HYDROPHOBICITY; INTESTINE CELL; LIPID DIET; LIVER CELL; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATIVE STRESS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BILE ACIDS AND SALTS; CELL DEATH; COLON; COLONIC NEOPLASMS; HUMANS; OXIDATIVE STRESS;

EID: 84875255442     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2012.12.020     Document Type: Review

References (146)

1. Akare S., Martinez J.D. Bile acid induces hydrophobicity-dependent membrane alterations. Biochim. Biophys. Acta 2005, 1735:59-67.
2. Akare S., Jean-Louis S., Chen W., Wood D.J., Powell A.A., Martinez J.D. Ursodeoxycholic acid modulates histone acetylation and induces differentiation and senescence. Int. J. Cancer 2006, 119:2958-2969.
3. Amaral J.D., Viana R.J., Ramalho R.M., Steer C.J., Rodrigues C.M. Bile acids: regulation of apoptosis by ursodeoxycholic acid. J. Lipid Res. 2009, 50:1721-1734.
4. Andoh A., Tsujikawa T., Fujiyama Y. Role of dietary fiber and short-chain fatty acids in the colon. Curr. Pharm. Des. 2003, 9:347-358.
5. Araki Y., Katoh T., Ogawa A., Bamba S., Andoh A., Koyama S., Fujiyama Y., Bamba T. Bile acid modulates transepithelial permeability via the generation of reactive oxygen species in the Caco-2 cell line. Free Radical Biol. Med. 2005, 39:769-780.
6. Baptissart M., Vega A., Maqdasy S., Caira F., Baron S., Lobaccaro J.M., Volle D.H. Bile acids: from digestion to cancers. Biochimie 2012, 10.1016/j.biochi.2012.06.022.
7. Barrasa J.I., Olmo N., Pérez-Ramos P., Santiago-Gómez A., Lecona E., Turnay J., Lizarbe M.A. Deoxycholic and chenodeoxycholic bile acids induce apoptosis via oxidative stress in human colon adenocarcinoma cells. Apoptosis 2011, 16:1054-1067.
8. Barrasa J.I., Santiago-Gómez A., Olmo N., Lizarbe M.A., Turnay J. Resistance to butyrate impairs bile acid-induced apoptosis in human colon adenocarcinoma cells via up-regulation of Bcl-2 and inactivation of Bax. Biochim. Biophys. Acta 2012, 1823:2201-2209.
9. Bayerdorffer E., Mannes G.A., Ochsenkuhn T., Dirschedl P., Wiebecke B., Paumgartner G. Unconjugated secondary bile acids in the serum of patients with colorectal adenomas. Gut 1995, 36:268-273.
10. Bernstein H., Holubec H., Warneke J.A., Garewal H., Earnest D.L., Payne C.M., Roe D.J., Cui H., Jacobson E.L., Bernstein C. Patchy field defects of apoptosis resistance and dedifferentiation in flat mucosa of colon resections from colon cancer patients. Ann. Surg. Oncol. 2002, 9:505-517.
11. Bernstein H., Payne C.M., Kunke K., Crowley-Weber C.L., Waltmire C.N., Dvorakova K., Holubec H., Bernstein C., Vaillancourt R.R., Raynes D.A., Guerriero V., Garewal H. A proteomic study of resistance to deoxycholate-induced apoptosis. Carcinogenesis 2004, 25:681-692.
12. Bernstein H., Bernstein C., Payne C.M., Dvorakova K., Garewal H. Bile acids as carcinogens in human gastrointestinal cancers. Mutat. Res. 2005, 589:47-65.
13. Bernstein H., Bernstein C., Payne C.M., Dvorak K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J. Gastroenterol. 2009, 15:3329-3340.
14. Bernstein C., Holubec H., Bhattacharyya A.K., Nguyen H., Payne C.M., Zaitlin B., Bernstein H. Carcinogenicity of deoxycholate, a secondary bile acid. Arch. Toxicol. 2011, 85:863-871.
15. Broker L.E., Kruyt F.A., Giaccone G. Cell death independent of caspases: a review. Clin. Cancer Res. 2005, 11:3155-3162.
16. Brossard D., El Kihel L., Clement M., Sebbahi W., Khalid M., Roussakis C., Rault S. Synthesis of bile acid derivatives and in vitro cytotoxic activity with pro-apoptotic process on multiple myeloma (KMS-11), glioblastoma multiforme (GBM), and colonic carcinoma (HCT-116) human cell lines. Eur. J. Med. Chem. 2010, 45:2912-2918.
17. Butler L.M., Wang R., Koh W.P., Stern M.C., Yuan J.M., Yu M.C. Marine n-3 and saturated fatty acids in relation to risk of colorectal cancer in Singapore Chinese: a prospective study. Int. J. Cancer 2009, 124:678-686.
18. Carroll K.K. Dietary fats and cancer. Am. J. Clin. Nutr. 1991, 53:1064S-1067S.
19. Cheng K., Raufman J.P. Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors. Biochem. Pharmacol. 2005, 70:1035-1047.
20. Chipuk J.E., Moldoveanu T., Llambi F., Parsons M.J., Green D.R. The BCL-2 family reunion. Mol. Cell 2010, 37:299-310.
21. Chowdhury I., Tharakan B., Bhat G.K. Current concepts in apoptosis: the physiological suicide program revisited. Cell. Mol. Biol. Lett. 2006, 11:506-525.
22. Cocco T., Di Paola M., Papa S., Lorusso M. Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation. Free Radical Biol. Med. 1999, 27:51-59.
23. Colitti M. BCL-2 family of proteins and mammary cellular fate. Anat. Histol. Embryol. 2012, 41:237-247.
24. Crowley-Weber C.L., Payne C.M., Gleason-Guzman M., Watts G.S., Futscher B., Waltmire C.N., Crowley C., Dvorakova K., Bernstein C., Craven M., Garewal H., Bernstein H. Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. Carcinogenesis 2002, 23:2063-2080.
25. de Bruin E.C., Medema J.P. Apoptosis and non-apoptotic deaths in cancer development and treatment response. Cancer Treat. Rev. 2008, 34:737-749.
26. De Gottardi A., Touri F., Maurer C.A., Perez A., Maurhofer O., Ventre G., Bentzen C.L., Niesor E.J., Dufour J.F. The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer. Dig. Dis. Sci. 2004, 49:982-989.
27. Debruyne P.R., Bruyneel E.A., Li X., Zimber A., Gespach C., Mareel M.M. The role of bile acids in carcinogenesis. Mutat. Res. 2001, 480-481:359-369.
28. Degirolamo C., Modica S., Palasciano G., Moschetta A. Bile acids and colon cancer: solving the puzzle with nuclear receptors. Trends Mol. Med. 2011, 17:564-572.
29. Denton D., Nicolson S., Kumar S. Cell death by autophagy: facts and apparent artefacts. Cell Death Differ. 2012, 19:87-95.
30. D'Errico I., Moschetta A. Nuclear receptors, intestinal architecture and colon cancer: an intriguing link. Cell. Mol. Life Sci. 2008, 65:1523-1543.
31. Desagher S., Martinou J.C. Mitochondria as the central control point of apoptosis. Trends Cell Biol. 2000, 10:369-377.
32. Dunai Z., Bauer P.I., Mihalik R. Necroptosis: biochemical, physiological and pathological aspects. Pathol. Oncol. Res. 2011, 17:791-800.
33. Estaquier J., Vallette F., Vayssiere J.L., Mignotte B. The mitochondrial pathways of apoptosis. Adv. Exp. Med. Biol. 2012, 942:157-183.
34. Fukiya S., Arata M., Kawashima H., Yoshida D., Kaneko M., Minamida K., Watanabe J., Ogura Y., Uchida K., Itoh K., Wada M., Ito S., Yokota A. Conversion of cholic acid and chenodeoxycholic acid into their 7-oxo derivatives by Bacteroides intestinalis AM-1 isolated from human feces. FEMS Microbiol. Lett. 2009, 293:263-270.
35. Garewal H., Bernstein H., Bernstein C., Sampliner R., Payne C. Reduced bile acid-induced apoptosis in "normal" colorectal mucosa: a potential biological marker for cancer risk. Cancer Res. 1996, 56:1480-1483.
36. Glick D., Barth S., Macleod K.F. Autophagy: cellular and molecular mechanisms. J. Pathol. 2010, 221:3-12.
37. Glinghammar B., Inoue H., Rafter J.J. Deoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity and the transcription factors NF-kB and AP-1. Carcinogenesis 2002, 23:839-845.
38. Gloire G., Legrand-Poels S., Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 2006, 72:1493-1505.
39. Ha Y.H., Park D.G. Effects of DCA on cell cycle proteins in colonocytes. J. Korean Soc. Coloproctol. 2010, 26:254-259.
40. Haza A.I., Glinghammar B., Grandien A., Rafter J. Effect of colonic luminal components on induction of apoptosis in human colonic cell lines. Nutr. Cancer 2000, 36:79-89.
41. Hofmann A.F. The continuing importance of bile acids in liver and intestinal disease. Arch. Int. Med. 1999, 159:2647-2658.
42. Hofmann A.F., Hagey L.R. Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell. Mol. Life Sci. 2008, 65:2461-2483.
43. Holubec H., Payne C.M., Bernstein H., Dvorakova K., Bernstein C., Waltmire C.N., Warneke J.A., Garewal H. Assessment of apoptosis by immunohistochemical markers compared to cellular morphology in ex vivo-stressed colonic mucosa. J. Histochem. Cytochem. 2005, 53:229-235.
44. Hong J., Behar J., Wands J., Resnick M., Wang L.J., DeLellis R.A., Lambeth D., Souza R.F., Spechler S.J., Cao W. Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma. Gut 2010, 59:170-180.
45. Hylemon P.B., Zhou H., Pandak W.M., Ren S., Gil G., Dent P. Bile acids as regulatory molecules. J. Lipid Res. 2009, 50:1509-1520.
46. Im E., Martinez J.D. Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells. J. Nutr. 2004, 134:483-486.
47. Jean-Louis S., Akare S., Ali M.A., Mash E.A., Meuillet E., Martinez J.D. Deoxycholic acid induces intracellular signaling through membrane perturbations. J. Biol. Chem. 2006, 281:14948-14960.
48. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
49. Katona B.W., Anant S., Covey D.F., Stenson W.F. Characterization of enantiomeric bile acid-induced apoptosis in colon cancer cell lines. J. Biol. Chem. 2009, 284:3354-3364.
50. Kawamata Y., Fujii R., Hosoya M., Harada M., Yoshida H., Miwa M., Fukusumi S., Habata Y., Itoh T., Shintani Y., Hinuma S., Fujisawa Y., Fujino M. A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 2003, 278:9435-9440.
51. Khare S., Cerda S., Wali R.K., von Lintig F.C., Tretiakova M., Joseph L., Stoiber D., Cohen G., Nimmagadda K., Hart J., Sitrin M.D., Boss G.R., Bissonnette M. Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer. Cancer Res. 2003, 63:3517-3523.
52. Kilbride S.M., Prehn J.H. Central roles of apoptotic proteins in mitochondrial function. Oncogene 2012, 10.1038/onc.2012.348.
53. Klee M., Pallauf K., Alcala S., Fleischer A., Pimentel-Muinos F.X. Mitochondrial apoptosis induced by BH3-only molecules in the exclusive presence of endoplasmic reticular Bak. EMBO J. 2009, 28:1757-1768.
54. Krammer P.H., Kaminski M., Kiessling M., Gulow K. No life without death. Adv. Cancer Res. 2007, 97:111-138.
55. Kure S., Nosho K., Baba Y., Irahara N., Shima K., Ng K., Meyerhardt J.A., Giovannucci E.L., Fuchs C.S., Ogino S. Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 2009, 18:2765-2772.
56. Kyriakis J.M., Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol. Rev. 2012, 92:689-737.
57. LaRue J.M., Stratagoules E.D., Martinez J.D. Deoxycholic acid-induced apoptosis is switched to necrosis by bcl-2 and calphostin C. Cancer Lett. 2000, 152:107-113.
58. 2+ entry at plasma membrane. Gastroenterology 2005, 128:695-707.
59. Lavrik I.N., Krammer P.H. Regulation of CD95/Fas signaling at the DISC. Cell Death Differ. 2012, 19:36-41.
60. Llambi F., Green D.R. Apoptosis and oncogenesis: give and take in the BCL-2 family. Curr. Opin. Genet. Dev. 2011, 21:12-20.
61. Long J.S., Ryan K.M. New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy. Oncogene 2012, 31:5045-5060.
62. Longpre J.M., Loo G. Protection of human colon epithelial cells against deoxycholate by rottlerin. Apoptosis 2008, 13:1162-1171.
63. Looby E., Long A., Kelleher D., Volkov Y. Bile acid deoxycholate induces differential subcellular localisation of the PKC isoenzymes beta 1, epsilon and delta in colonic epithelial cells in a sodium butyrate insensitive manner. Int. J. Cancer 2005, 114:887-895.
64. López de Silanes I., Olmo N., Turnay J., González de Buitrago G., Pérez-Ramos P., Guzmán-Aránguez A., García-Díez M., Lecona E., Gorospe M., Lizarbe M.A. Acquisition of resistance to butyrate enhances survival after stress and induces malignancy of human colon carcinoma cells. Cancer Res. 2004, 64:4593-4600.
65. Lu J.V., Walsh C.M. Programmed necrosis and autophagy in immune function. Immunol. Rev. 2012, 249:205-217.
66. Mahmood Z., Shukla Y. Death receptors: targets for cancer therapy. Exp. Cell Res. 2010, 316:887-899.
67. Maran R.R., Thomas A., Roth M., Sheng Z., Esterly N., Pinson D., Gao X., Zhang Y., Ganapathy V., Gonzalez F.J., Guo G.L. Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development. J. Pharmacol. Exp. Ther. 2009, 328:469-477.
68. Marchetti C., Migliorati G., Moraca R., Riccardi C., Nicoletti I., Fabiani R., Mastrandrea V., Morozzi G. Deoxycholic acid and SCFA-induced apoptosis in the human tumor cell-line HT-29 and possible mechanisms. Cancer Lett. 1997, 114:97-99.
69. Martinez J.D., Stratagoules E.D., LaRue J.M., Powell A.A., Gause P.R., Craven M.T., Payne C.M., Powell M.B., Gerner E.W., Earnest D.L. Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation. Nutr. Cancer 1998, 31:111-118.
70. Matés J.M., Segura J.A., Alonso F.J., Márquez J. Oxidative stress in apoptosis and cancer: an update. Arch. Toxicol. 2012, 86:1649-1665.
71. Milovic V., Teller I.C., Faust D., Caspary W.F., Stein J. Effects of deoxycholate on human colon cancer cells: apoptosis or proliferation. Eur. J. Clin. Invest. 2002, 32:29-34.
72. Mitsuyoshi H., Nakashima T., Sumida Y., Yoh T., Nakajima Y., Ishikawa H., Inaba K., Sakamoto Y., Okanoue T., Kashima K. Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants. Biochem. Biophys. Res. Commun. 1999, 263:537-542.
73. Modica S., Murzilli S., Salvatore L., Schmidt D.R., Moschetta A. Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. Cancer Res. 2008, 68:9589-9594.
74. Monte M.J., Marin J.J., Antelo A., Vazquez-Tato J. Bile acids: chemistry, physiology, and pathophysiology. World J. Gastroenterol. 2009, 15:804-816.
75. Morgan M.J., Liu Z.G. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res. 2011, 21:103-115.
76. Nagata S. Apoptosis and autoimmune diseases. Ann. N. Y. Acad. Sci. 2010, 1209:10-16.
77. Odermatt A., Da Cunha T., Penno C.A., Chandsawangbhuwana C., Reichert C., Wolf A., Dong M., Baker M.E. Hepatic reduction of the secondary bile acid 7-oxolithocholic acid is mediated by 11beta-hydroxysteroid dehydrogenase 1. Biochem. J. 2011, 436:621-629.
78. Olmo N., Turnay J., Lecona E., García-Díez M., Llorente B., Santiago-Gómez A., Lizarbe M.A. Acquisition of resistance to butyrate induces resistance to luminal components and other types of stress in human colon adenocarcinoma cells. Toxicol. In Vitro 2007, 21:254-261.
79. Ou J., DeLany J.P., Zhang M., Sharma S., O'Keefe S.J. Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations. Nutr. Cancer 2012, 64:34-40.
80. Ow Y.P., Green D.R., Hao Z., Mak T.W. Cytochrome c: functions beyond respiration. Nat. Rev. Mol. Cell Biol. 2008, 9:532-542.
81. Pai R., Tarnawski A.S., Tran T. Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness. Mol. Biol. Cell 2004, 15:2156-2163.
82. Palmeira C.M., Rolo A.P. Mitochondrially-mediated toxicity of bile acids. Toxicology 2004, 203:1-15.
83. Paumgartner G., Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002, 36:525-531.
84. Payne C.M., Bernstein H., Bernstein C., Garewal H. Role of apoptosis in biology and pathology: resistance to apoptosis in colon carcinogenesis. Ultrastruct. Pathol. 1995, 19:221-248.
85. Payne C.M., Crowley-Weber C.L., Dvorak K., Bernstein C., Bernstein H., Holubec H., Crowley C., Garewal H. Mitochondrial perturbation attenuates bile acid-induced cytotoxicity. Cell Biol. Toxicol. 2005, 21:215-231.
86. Payne C.M., Weber C., Crowley-Skillicorn C., Dvorak K., Bernstein H., Bernstein C., Holubec H., Dvorakova B., Garewal H. Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells. Carcinogenesis 2007, 28:215-222.
87. Payne C.M., Bernstein C., Dvorak K., Bernstein H. Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis. Clin Exp Gastroenterol 2008, 1:19-47.
88. Peiffer L.P., Peters D.J., McGarrity T.J. Differential effects of deoxycholic acid on proliferation of neoplastic and differentiated colonocytes in vitro. Dig. Dis. Sci. 1997, 42:2234-2240.
89. Peiró-Jordán R., Krishna-Subramanian S., Hanski M.L., Luscher-Firzlaff J., Zeitz M., Hanski C. The chemopreventive agent ursodeoxycholic acid inhibits proliferation of colon carcinoma cells by suppressing c-Myc expression. Eur. J. Cancer Prev. 2012, 21:413-422.
90. Perez M.J., Briz O. Bile-acid-induced cell injury and protection. World J. Gastroenterol. 2009, 15:1677-1689.
91. Pérez-Ramos P., Olmo N., Turnay J., Lecona E., González de Buitrago G., Portolés M.T., Lizarbe M.A. Effect of bile acids on butyrate-sensitive and -resistant human colon adenocarcinoma cells. Nutr. Cancer 2005, 53:208-219.
92. Potten C.S. Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos. Trans. Roy. Soc. Lond. B Biol. Sci. 1998, 353:821-830.
93. Potten C.S., Wilson J.W., Booth C. Regulation and significance of apoptosis in the stem cells of the gastrointestinal epithelium. Stem cells 1997, 15:82-93.
94. Powell A.A., LaRue J.M., Batta A.K., Martinez J.D. Bile acid hydrophobicity is correlated with induction of apoptosis and/or growth arrest in HCT116 cells. Biochem. J. 2001, 356:481-486.
95. Powell A.A., Akare S., Qi W., Herzer P., Jean-Louis S., Feldman R.A., Martinez J.D. Resistance to ursodeoxycholic acid-induced growth arrest can also result in resistance to deoxycholic acid-induced apoptosis and increased tumorgenicity. BMC Cancer 2006, 6:219.
96. Powolny A., Xu J., Loo G. Deoxycholate induces DNA damage and apoptosis in human colon epithelial cells expressing either mutant or wild-type p53. Int. J. Biochem. Cell Biol. 2001, 33:193-203.
97. Qiao D., Gaitonde S.V., Qi W., Martinez J.D. Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation. Carcinogenesis 2001, 22:957-964.
98. Qiao D., Stratagouleas E.D., Martinez J.D. Activation and role of mitogen-activated protein kinases in deoxycholic acid-induced apoptosis. Carcinogenesis 2001, 22:35-41.
99. Qiao D., Im E., Qi W., Martinez J.D. Activator protein-1 and CCAAT/enhancer-binding protein mediated GADD153 expression is involved in deoxycholic acid-induced apoptosis. Biochim. Biophys. Acta 2002, 1583:108-116.
100. Radtke F., Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 2005, 307:1904-1909.
101. Rasheva V.I., Domingos P.M. Cellular responses to endoplasmic reticulum stress and apoptosis. Apoptosis 2009, 14:996-1007.
102. Reddy B.S. Diet and excretion of bile acids. Cancer Res. 1981, 41:3766-3768.
103. Reddy B.S., Wynder E.L. Metabolic epidemiology of colon cancer. Fecal bile acids and neutral sterols in colon cancer patients and patients with adenomatous polyps. Cancer 1977, 39:2533-2539.
104. Reddy B.S., Hanson D., Mangat S., Mathews L., Sbaschnig M., Sharma C., Simi B. Effect of high-fat, high-beef diet and of mode of cooking of beef in the diet on fecal bacterial enzymes and fecal bile acids and neutral sterols. J. Nutr. 1980, 110:1880-1887.
105. Reinehr R., Becker S., Keitel V., Eberle A., Grether-Beck S., Haussinger D. Bile salt-induced apoptosis involves NADPH oxidase isoform activation. Gastroenterology 2005, 129:2009-2031.
106. Renehan A.G., Bach S.P., Potten C.S. The relevance of apoptosis for cellular homeostasis and tumorigenesis in the intestine. Can. J. Gastroenterol. 2001, 15:166-176.
107. Riegler M., Feil W., Lindroth J., Wong M. MIPSY: real-time morphometry to quantify the time course of rapid epithelial restitution. Pathol. Res. Pract. 1992, 188:443-448.
108. Rodrigues C.M., Fan G., Wong P.Y., Kren B.T., Steer C.J. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol. Med. 1998, 4:165-178.
109. Rodrigues C.M., Ma X., Linehan-Stieers C., Fan G., Kren B.T., Steer C.J. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ. 1999, 6:842-854.
110. Rodrigues C.M., Sola S., Sharpe J.C., Moura J.J., Steer C.J. Tauroursodeoxycholic acid prevents Bax-induced membrane perturbation and cytochrome C release in isolated mitochondria. Biochemistry 2003, 42:3070-3080.
111. Roma M.G., Toledo F.D., Boaglio A.C., Basiglio C.L., Crocenzi F.A., Sanchez Pozzi E.J. Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications. Clin. Sci. (Lond.) 2011, 121:523-544.
112. Rosignoli P., Fabiani R., De Bartolomeo A., Spinozzi F., Agea E., Pelli M.A., Morozzi G. Protective activity of butyrate on hydrogen peroxide-induced DNA damage in isolated human colonocytes and HT29 tumour cells. Carcinogenesis 2001, 22:1675-1680.
113. Rosignoli P., Fabiani R., De Bartolomeo A., Fuccelli R., Pelli M.A., Morozzi G. Genotoxic effect of bile acids on human normal and tumour colon cells and protection by dietary antioxidants and butyrate. Eur. J. Nutr. 2008, 47:301-309.
114. Saab R. Senescence and pre-malignancy: how do tumors progress?. Semin. Cancer Biol. 2011, 21:385-391.
115. Saeki T., Yui S., Hirai T., Fujii T., Okada S., Kanamoto R. Ursodeoxycholic acid protects colon cancer HCT116 cells from deoxycholic acid-induced apoptosis by inhibiting apoptosome formation. Nutr. Cancer 2012, 64:617-626.
116. Sakamoto K., Maeda S. Targeting NF-kappaB for colorectal cancer. Expert Opin. Ther. Targets 2010, 14:593-601.
117. Schlottman K., Wachs F.P., Krieg R.C., Kullmann F., Scholmerich J., Rogler G. Characterization of bile salt-induced apoptosis in colon cancer cell lines. Cancer Res. 2000, 60:4270-4276.
118. Schultz D.R., Harrington W.J. Apoptosis: programmed cell death at a molecular level. Semin. Arthritis Rheum. 2003, 32:345-369.
119. Serfaty L., Bissonnette M., Poupon R. Ursodeoxycholic acid and chemoprevention of colorectal cancer. Gastroenterol. Clin. Biol. 2010, 34:516-522.
120. Shah S.A., Looby E., Volkov Y., Long A., Kelleher D. Ursodeoxycholic acid inhibits translocation of protein kinase C in human colonic cancer cell lines. Eur. J. Cancer 2005, 41:2160-2169.
121. Shah S.A., Volkov Y., Arfin Q., Abdel-Latif M.M., Kelleher D. Ursodeoxycholic acid inhibits interleukin 1β and deoxycholic acid-induced activation of NF-κB and AP-1 in human colon cancer cells. Int. J. Cancer 2006, 118:532-539.
122. Shant J., Cheng K., Marasa B.S., Wang J.Y., Raufman J.P. Akt-dependent NF-kappaB activation is required for bile acids to rescue colon cancer cells from stress-induced apoptosis. Exp. Cell Res. 2009, 315:432-450.
123. Siddiqui K.M., Chopra D.P. Primary and long term epithelial cell cultures from human fetal normal colonic mucosa. In Vitro 1984, 20:859-868.
124. Solimando R., Bazzoli F., Ricciardiello L. Chemoprevention of colorectal cancer: a role for ursodeoxycholic acid, folate and hormone replacement treatment?. Best Pract. Res. Clin. Gastroenterol. 2011, 25:555-568.
125. Soucek K., Gajduskova P., Brazdova M., Hyzd'alova M., Koci L., Vydra D., Trojanec R., Pernicova Z., Lentvorska L., Hajduch M., Hofmanova J., Kozubik A. Fetal colon cell line FHC exhibits tumorigenic phenotype, complex karyotype, and TP53 gene mutation. Cancer Genet. Cytogenet. 2010, 197:107-116.
126. Sperandio S., de Belle I., Bredesen D.E. An alternative, nonapoptotic form of programmed cell death. Proc. Natl. Acad. Sci. USA 2000, 97:14376-14381.
127. Stadler J., Stern H.S., Yeung K.S., McGuire V., Furrer R., Marcon N., Bruce W.R. Effect of high fat consumption on cell proliferation activity of colorectal mucosa and on soluble faecal bile acids. Gut 1988, 29:1326-1331.
128. Taylor R.C., Cullen S.P., Martin S.J. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 2008, 9:231-241.
129. Thomas C., Gioiello A., Noriega L., Strehle A., Oury J., Rizzo G., Macchiarulo A., Yamamoto H., Mataki C., Pruzanski M., Pellicciari R., Auwerx J., Schoonjans K. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 2009, 10:167-177.
130. Tong J.L., Ran Z.H., Shen J., Fan G.Q., Xiao S.D. Association between fecal bile acids and colorectal cancer: a meta-analysis of observational studies. Yonsei Med. J. 2008, 49:792-803.
131. Tung B.Y., Emond M.J., Haggitt R.C., Bronner M.P., Kimmey M.B., Kowdley K.V., Brentnall T.A. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann. Int. Med. 2001, 134:89-95.
132. Vakifahmetoglu H., Olsson M., Zhivotovsky B. Death through a tragedy: mitotic catastrophe. Cell Death Differ. 2008, 15:1153-1162.
133. Velazquez O.C., Seto R.W., Choi J., Zhou D., Breen F., Fisher J.D., Rombeau J.L. Butyrate inhibits deoxycholate-induced increase in colonic mucosal DNA and protein synthesis in vivo. Dis. Colon Rectum 1997, 40:1368-1375.
134. Wachs F.P., Krieg R.C., Rodrigues C.M., Messmann H., Kullmann F., Knuchel-Clarke R., Scholmerich J., Rogler G., Schlottmann K. Bile salt-induced apoptosis in human colon cancer cell lines involves the mitochondrial transmembrane potential but not the CD95 (Fas/Apo-1) receptor. Int. J. Colorectal Dis. 2005, 20:103-113.
135. Washo-Stultz D., Crowley C., Payne C.M., Bernstein C., Marek S., Gerner E.W., Bernstein H. Increased susceptibility of cells to inducible apoptosis during growth from early to late log phase: an important caveat for in vitro apoptosis research. Toxicol. Lett. 2000, 116:199-207.
136. Washo-Stultz D., Crowley-Weber C.L., Dvorakova K., Bernstein C., Bernstein H., Kunke K., Waltmire C.N., Garewal H., Payne C.M. Role of mitochondrial complexes I and II, reactive oxygen species and arachidonic acid metabolism in deoxycholate-induced apoptosis. Cancer Lett. 2002, 177:129-144.
137. Wirawan E., Vanden Berghe T., Lippens S., Agostinis P., Vandenabeele P. Autophagy: for better or for worse. Cell Res. 2012, 22:43-61.
138. Wong R.S. Apoptosis in cancer: from pathogenesis to treatment. J. Exp. Clin. Cancer Res. 2011, 30:87.
139. Wood N.J. Primary biliary cirrhosis: fenofibrate plus UDCA promising for incomplete responders to UDCA. Nat. Rev. Gastroenterol. Hepatol. 2011, 8:63.
140. Wu W., Liu P., Li J. Necroptosis: an emerging form of programmed cell death. Crit. Rev. Oncol. Hematol. 2012, 82:249-258.
141. Yasuda H., Hirata S., Inoue K., Mashima H., Ohnishi H., Yoshiba M. Involvement of membrane-type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-activated protein kinases in gastric carcinoma cells. Biochem. Biophys. Res. Commun. 2007, 354:154-159.
142. Yui S., Saeki T., Kanamoto R., Iwami K. Characteristics of apoptosis in HCT116 colon cancer cells induced by deoxycholic acid. J. Biochem. 2005, 138:151-157.
143. Yui S., Kanamoto R., Saeki T. Deoxycholic acid can induce apoptosis in the human colon cancer cell line HCT116 in the absence of Bax. Nutr. Cancer 2008, 60:91-96.
144. Yui S., Kanamoto R., Saeki T. Biphasic regulation of cell death and survival by hydrophobic bile acids in HCT116 cells. Nutr. Cancer 2009, 61:374-380.
145. Zheng Z.Y., Bernstein H., Bernstein C., Payne C.M., Martinez J.D., Gerner E.W. Bile acid activation of the gadd153 promoter and of p53-independent apoptosis: relevance to colon cancer. Cell Death Differ. 1996, 3:407-414.
146. Zhou J., Liu M., Zhai Y., Xie W. The antiapoptotic role of pregnane X receptor in human colon cancer cells. Mol. Endocrinol. 2008, 22:868-880.